Cart
sales@molnova.com
6-Chloro-1-tetralone
CAS No. 26673-31-4
6-Chloro-1-tetralone( 6-chloro-3 | 5-CHLORO-1-INDOMONE | 5-CHLORO-L-INDOMONE | 6-Chloro-α-Tetralone | 6-Chloro-1-tetralone )
Catalog No. M27393 CAS No. 26673-31-4
6-Chloro-1-tetralone is an important intermediate for the synthesis of pharmaceutical compounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-Chloro-1-tetralone
-
NoteResearch use only, not for human use.
-
Brief Description6-Chloro-1-tetralone is an important intermediate for the synthesis of pharmaceutical compounds.
-
Description6-Chloro-1-tetralone is an important intermediate for the synthesis of pharmaceutical compounds.
-
In Vitro——
-
In Vivo——
-
Synonyms6-chloro-3 | 5-CHLORO-1-INDOMONE | 5-CHLORO-L-INDOMONE | 6-Chloro-α-Tetralone | 6-Chloro-1-tetralone
-
PathwayOthers
-
TargetOther Targets
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number26673-31-4
-
Formula Weight180.63
-
Molecular FormulaC10H9ClO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1ccc2C(=O)CCCc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Affiliatio, et al. Antimycobacterial activities of oxazolidinones: a review. Infect Disord Drug Targets. 2006 Dec;6(4):343-54.
molnova catalog
related products
-
3-Angeloyloxy-4-sene...
3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol is a natural product for research related to life sciences.
-
(-)-p-Bromotetramiso...
p-Bromotetramisole Oxalate is a potent and non-specific alkaline phosphatase inhibitor.
-
Etelcalcetide hydroc...
Etelcalcetide hydrochloride (AMG 416 hydrochloride) is a synthetic peptide as an allosteric modulator of the calcium (Ca)-sensing receptor (CaSR). Etelcalcetide hydrochloride is effective in lowering parathyroid hormone (PTH) concentrations in patients receiving dialysis with secondary hyperparathyroidism receiving hemodialysis.
